Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin

Journal of Neurochemistry

Volumn 80, Issue 4, 2002, Pages 667-677

  Antonetti, David A ^a   Wolpert, Ellen B ^a   DeMaio, Lucas ^a   Harhaj, Nicole S ^a   Scaduto, Russell C ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Blood retinal barrier; Brain tumor; Diabetic retinopathy; Tight junctions

Indexed keywords

BUFFER; HYDROCORTISONE; MESSENGER RNA; OCCLUDIN; UREA;

ANIMAL CELL; ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; EXTRACTION; HORMONE ACTION; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; RETINA CELL; RETINA EDEMA; SOLUTE; STEROID THERAPY; WATER CONTENT; WATER TRANSPORT;

ANIMALS; CATTLE; CELLS, CULTURED; ENDOTHELIUM; HYDROCORTISONE; MEMBRANE PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; RETINA; RNA, MESSENGER; TIGHT JUNCTIONS; WATER;

ANIMALIA; BOVINAE;

EID: 0036323373     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-3042.2001.00740.x     Document Type: Article

References (63)

1. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
2. Vascular endothelial growth factor and the eye: Biochemical mechanisms of action and implications for novel therapies
3. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
4. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy
5. Tight junctions and the molecular basis for regulation of paracellular permeability
6. Characterization of ZO-1, a protein component of the tight junction from mouse liver and Madin-Darby canine kidney cells
7. Zonula occludens (ZO)-1 and ZO-2: Membrane-associated guanylate kinase homologues (MAGuKs) of the tight junction
8. Interspecies diversity of the occludin sequence: cDNA cloning of human, mouse, dog, and rat-kangaroo homologues
9. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications trial
10. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content
11. Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors
12. Molecular mechanisms of vascular permeability in diabetic retinopathy
13. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes
14. Transforming growth factor-alpha abrogates glucocorticoid-stimulated tight junction formation and growth suppression in rat mammary epithelial tumor cells
15. Effect of vascular endothelial growth factor on cultured endothelial cell monolayer transport properties
16. COOH terminus of occludin is required for tight junction barrier function in early xenopus embryos
17. Tight junction proteins
18. Studies on the permeability of the blood-retinal barrier. I. On the existence, development, and site of a blood-retinal barrier
19. Shear stress regulates occludin content and phosphorylation
20. Molecular structure and assembly of the tight junction
21. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton
22. Junctional complexes in various epithelia
23. The use of steriods for control of cerebral edema
24. Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions
25. Manner of interaction of heterogeneous claudin species within and between tight junction strands
26. Histamine reduces ZO-1 tight-junction protein expression in cultured retinal microvascular endothelial cells
27. The gap junction protein connexin43 interacts with the second PDZ domain of the zona occludens-1 protein
28. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes
29. Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat
30. Real time quantitative PCR
31. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor
32. Occludin as a possible determinant of tight junction permeability in endothelial cells
33. Hydrocortisone reinforces the blood-brain properties in a serum free cell culture system
34. Involvement of ZO-1 in cadherin-based cell adhesion through its direct binding to α catenin and actin filaments
35. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2 and ZO-3, with the COOH termini of claudins
36. Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins
37. Expression of zonula occludens and adherens junctional proteins in human venous and arterial endothelial cells: Role of occludin in endothelial solute barriers
38. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema
39. Effect of VEGF on retinal microvascular endothelial hydraulic conductivity: The role of NO
40. Localization of vascular endothelial growth factor in human retina and choroid
41. Occludin and the functions of tight junctions
42. Occludin is a functional component of the tight junction
43. Vascular endothelial growth factor and ocular neovascularization
44. Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy
45. Molecular architecture of tight junctions
46. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands
47. Endothelial claudin: Claudin-5/TMVCF constitutes tight junction strands in endothelial cells
48. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas
49. Growth factors and diabetic retinopathy
50. Fine structural localization of a blood-brain barrier to exogenous peroxidase
51. Use of glucocorticoids in the paliative treatment of metastatic brain tumors
52. Complex phenotype of mice lacking occludin, a component of tight junction strands
53. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions
54. Studies on the permeability of the blood-retinal barrier. IV. Junctional complexes of the retinal vessels and their role in the permeability of the blood-retinal barrier
55. Relationship of serine/threonine phosphorylation/dephosphorylation signaling to glucocorticoid regulation of tight junction permeability and ZO-1 distribution in nontransformed mammary epithelial cells
56. Further observations on the fine structure of freeze-cleaved tight junctions
57. Prolactin, alone or in combination with glucocorticoids, enhances tight junction formation and expression of the tight junction protein occludin in mammary cells
58. The tight junction: Morphology to molecules
59. Occludin confers adhesiveness when expressed fibroblasts
60. Clinically significant macular edema in type I diabetes
61. Protein interactions at the tight junction-Actin has multiple binding partners, and ZO-1 forms independent complexes with ZO-2 and ZO-3
62. Physiologic transport properties of cultured retinal microvascular endothelial cell monolayers
63. Glucocorticoid-induced formation of tight junctions in mouse mammary epithelial cells in vitro